Molecular Farming Market is expected to increase at a compound annual growth rate (CAGR) of 9.0% from 2025 to 2035

 

The molecular farming market was estimated to be worth USD 1.7 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 9.0% to reach USD 3.2 billion in 2035. Because genetically modified plants and animals are relatively cheap to produce and care for, molecular farming is a helpful substitute for conventional pharmaceutical development.

The creation of proteins or other metabolites useful for industry or medicine from plants typically used in agriculture is known as "molecular farming." Numerous proteins free of infections and poisons from mammals can be produced by crop plants. Crop plants need few facilities and generate a lot of biomass at a low cost. Molecular farming is a novel source of molecular medicines, such as plasma proteins, enzymes, growth factors, vaccines, and recombinant antibodies, whose medical applications are known at a molecular level. Plants have long been employed as a source of therapeutic chemicals.

 

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/molecular-farming-market

 

GROWTH DRIVERS

One of the main factors driving the market is the latest advancements in genetic engineering, which makes it possible to produce complex proteins and biopharmaceuticals in plants as well as edit pant genomes with extreme accuracy. The Military Medical Journal claims that significant advances in life science and medicine have resulted from the quick development of genome editing technologies.

Adoption is fueled by advances in genetic engineering, such as CRISPR technology, which increases efficiency and precision. The market is expanding due to the growing need for biopharmaceuticals, such as vaccines, antibodies, and other products, where molecular farming is more affordable than conventional cell culture systems for the production of these high-value goods.

Because these biological products are stable, safe, effective, readily available, and reasonably priced, the market for essential medications and treatments is being adopted on a global scale. The market is expanding due to increased funding and investment from the public and private sectors. For example, the Agricultural Marketing Service (AMS) of the U.S. Department of Agriculture (USDA) announced today that 55 states and territories will receive USD 72.9 million under the Specialty Crop Block Grant Program (SCBGP) in August 2023.

MARKET SEGMENTATION:

·         By Product Type- recombinant proteins, vaccines and others

·         By Technique- plant and animal

·         By End-Users- academic and research institutes, pharmaceutical and biotechnology companies, agricultural companies and others

·         By Region- North America, Europe, Asia Pacific, Middle East and Africa, South America

Global Key Players:

·         Pharming Group NV

·         Medicargo

·         Mapp Biopharmaceutical

·         Miruku

·         Mozza

·         Nobell Foods

·         Corebiogenesis

·         Kbio

·         Orf Genetics

·         Plantform

·         Other Players

 

For More Information about this Report @ https://www.xresearch.biz/shop/molecular-farming-market

 

About Us: -  

xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

                                   

Contact:                                           
Company Name:  xResearch
Contact Person:  James Lin
Email:  sales@xresearch.biz
Phone: +1 718-619-8140

Websites: https://www.xresearch.biz/